Isogenica will be attending The One Nucleus flagship conference, On Helix.
On Helix provides an excellent opportunity to bring the network together to present and discuss the main innovation and technology trends in healthcare research and development.
Following 2020 and the way the life science community combined resources, ingenuity and hard work to deliver prophylactic and therapeutic tools against the pandemic, many lessons can be learnt on better translating science and developing therapeutics and healthcare technologies.
Throughout the one and a half days of ON Helix, our Director of Business Development, Dr David Mead, and Associate Director of Marketing, Dr Mandeep Sehmi, will observe talks that will address the latest innovations and technologies in Medicines.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.